Acyclovir Therapy
Acyclovir Therapy is a pharmacotherapeutic intervention that belongs to the class of antiviral treatments and is specifically distinguished by its use of the nucleoside analogue acyclovir to selectively inhibit herpes simplex virus (HSV) DNA replication in the management of sexually transmitted infections caused by HSV types 1 and 2.
2.5K
Publications
129.4K
Citations
9.5K
Authors
2.2K
Institutions
Publications per year
2017–2026
247
2.5K
Early Treatment with Prednisolone or Acyclovir in Bell's Palsy
Frank Sullivan, Iain Swan, Peter T. Donnan et al. · New England Journal of Medicine · 2007 · 755 citations · Full text
1–5 of 2.5K
9.5K
36
h-index
32
h-index
26
h-index
23
h-index
University of Alabama at Birmingham, United States
23 publications · 4.8K citations
22
h-index
1–5 of 9.5K
2.2K

Research Triangle Park Foundation
Durham, United States
48 h-index
273 publications
24K citations
University of Washington
Seattle, United States
47 h-index
353 publications
31.8K citations
Wellcome Trust
London, United Kingdom
35 h-index
161 publications
12.2K citations
Fred Hutch Cancer Center
Seattle, United States
33 h-index
185 publications
15.5K citations
Rega Institute for Medical Research
Leuven, Belgium
32 h-index
179 publications
9.5K citations
Burroughs Wellcome Fund
Durham, United States
31 h-index
147 publications
15.3K citations

University of Minnesota
Minneapolis, United States
30 h-index
140 publications
17K citations
KU Leuven
Leuven, Belgium
30 h-index
147 publications
7.8K citations
1–8 of 2.2K
JID · 110 publications · 8.3K citations
58
h-index
AAC · 179 publications · 11.1K citations
57
h-index
Repository · 212 publications · 7.6K citations
46
h-index
CID · 53 publications · 4.4K citations
35
h-index
53 publications · 2.4K citations
30
h-index
1–5